Ventilator Associated Pneumonia (VAP) EMCrit Project Ventilator associated pneumonia (VAP) and pleural empyema caused by multidrug resistant Acinetobacter baumannii in HIV and COVID 19 infected patient: A case report ScienceDirect Frontiers Oral care medications for the prevention and treatment of ventilator associated pneumonia in intensive care unit VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds The spectrum of pneumonia among intubated neonates in the neonatal intensive care unit Journal of Perinatology Figure 1 from Ventilator associated pneumonia: a review. Semantic Scholar